
Olmenol T 40mg/10mg/12.5mg Tablet
Marketer
Fawn Incorporation
Salt Composition
Olmesartan Medoxomil (40mg) + Cilnidipine (10mg) + Chlorthalidone (12.5mg)
Overview Olmenol T 40mg/10mg/12.5mg Tablet
Triamterene/Olmesartan/Hydrochlorothiazide 40mg/10mg/12.5mg tablets combine three medications to manage hypertension when monotherapy proves insufficient. This formulation lowers elevated blood pressure, mitigating the risk of future strokes and heart attacks. Administer this medication with food, at the same time daily, following your doctor's prescribed dosage based on individual response. Continuous use, as directed, is crucial; discontinuation may increase stroke or heart attack risk. As this triple combination includes a diuretic, increased urination is expected; avoid dosing within four hours of bedtime. Consistent use maximizes therapeutic benefit, even in the absence of noticeable symptoms (high blood pressure is often asymptomatic). Common side effects such as ankle edema, headache, dizziness, fatigue, and altered taste sensation warrant consultation if persistent, worsening, or bothersome. Maintain adequate hydration to counter potential side effects like muscle weakness, dry mouth, and thirst. Prior to commencing treatment, disclose any liver or kidney conditions, pregnancy, or breastfeeding to your physician. Full disclosure of all concurrent medications, particularly those for hypertension or cardiac issues, is essential. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is necessary to optimize treatment efficacy and safety.
Uses of Olmenol T 40mg/10mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Olmenol T 40mg/10mg/12.5mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Olmenol T 40mg/10mg/12.5mg Tablet should be administered with a meal.
Common Side effects of Olmenol T 40mg/10mg/12.5mg Tablet:
- Ankle swelling
- Headache
- Dizziness
- Tiredness
- Palpitations
- Sleepiness
- Increased blood uric acid
- Glucose intolerance
- Taste change
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Upset stomach
- Altered blood lipid level
How to use Olmenol T 40mg/10mg/12.5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Olmenol T 40mg/10mg/12.5mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
How Olmenol T 40mg/10mg/12.5mg Tablet works:
Each Olmenol T 40mg/10mg/12.5mg tablet unites olmesartan medoxomil (an angiotensin receptor blocker or ARB), cilnidipine (a calcium channel blocker or CCB), and chlorthalidone (a diuretic). Olmesartan medoxomil and cilnidipine lower blood pressure by promoting vasodilation, relaxing blood vessels. Chlorthalidone facilitates diuresis, eliminating excess fluid and electrolytes, and contributes to vasodilation and improved circulation over the long term.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Olmenol T 40mg/10mg/12.5mg tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using Olmenol T 40mg/10mg/12.5mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use justified if the potential advantages outweigh the hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Olmenol T 40mg/10mg/12.5mg Tablet with breastfeeding are lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Olmenol T 40mg/10mg/12.5mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Olmenol T 40mg/10mg/12.5mg tablets. Dosage modification may be necessary; physician consultation is advised. This medication is generally not recommended for individuals with such conditions.
LiverCAUTION
Patients with liver impairment should use Olmenol T 40mg/10mg/12.5mg tablets cautiously, potentially requiring dosage modification. Medical advice is recommended. Olmenol T 40mg/10mg/12.5mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Olmenol T 40mg/10mg/12.5mg Tablet :
Should you forget to take your Olmenol T 40mg/10mg/12.5mg Tablet, ingest it immediately. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Olmenol T 40mg/10mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Heart |
